Connect with us

News

WHO Certifies New HIV Treatment Drug

Published

on

An antiretroviral drug dolutegravir, commonly known as DTG, has been certified safe for use by pregnant women and those in their reproductive years by the World Health Organisation (WHO).

Though initial research linked the drug with neural tube defects (NTDs) in infants born to women using dolutegravir at the time of conception, recent studies have shown that it is far more tolerable than the older drug efavirenz, which patients have reported causes depression and hallucinations in the first few months and could lead to people not staying on treatment.

“DTG is a drug that is more effective, easier to take and has fewer side effects than alternative drugs that are currently used. DTG also has a high genetic barrier to developing drug resistance, which is important given the rising trend of resistance to efavirenz and nevirapine-based regimens,” states the WHO.

WHO in a statement shared on its official website on Monday, said that the DTG drug is now more effective, easier to take and has fewer side effects than alternative drugs that are currently used.

“DTG also has a high genetic barrier to developing drug resistance, which is important given the rising trend of resistance to EFV and nevirapine-based regimens.

“In 2019, 12 out of 18 countries surveyed by WHO reported pre-treatment drug resistance levels exceeding the recommended threshold of 10 per cent.

“All of above findings informed the decision to update the 2019 guidelines, and the newly updated recommendations aim to help more countries improve their HIV policies,” WHO said.

”For any medications, informed choice is important as every treatment decision needs to be based on an informed discussion with the health provider weighing the benefits and potential risks,” it said.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Nigerian Doctor Planning To Relocate To The UK Slvmps And Ð!es After Being On Duty For 72-hours

Published

on

The Nigerian medical community is reeling from the devastating loss of Dr. Oluwafemi “Femi” Rotifa, a young doctor at the Rivers State University Teaching Hospital (RSUTH) whose life ended just as a new chapter was about to begin.

Dr. Femi had already completed his registration with the UK’s General Medical Council and concluded all plans to relocate for better opportunities abroad. He was days away from starting a fresh life when tragedy struck.

After working a grveling 72-hour call shift at RSUTH’s Emergency Room, he reportedly went to the call room to rest but slumped and never woke up. Despite resuscitation efforts at the ICU, he was pronounced gone—leaving behind family, friends, and colleagues in deep shock.

His passing has been described by the Nigerian Association of Resident Doctors (NARD) and the Nigerian Medical Association (NMA) as a preventable death, one that reflects the harsh reality of overworked and under-supported doctors in Nigeria.

Dr. Femi’s story is both heartbreaking and eye-opening: a young man full of promise, already on the path to building a brighter future abroad, cut down by the very system he gave his all to serve.

Continue Reading

News

Mohbad: I Have Always Been Ready For The DNA Test – Wunmi

Published

on

Mohbad’s wife, Omowunmi “Wunmi” Aloba, has finally reacted after the Ikorodu Magistrate Court ordered that a DNA test be conducted on her son, Liam. The court directed that two separate tests be carried out—one in Nigeria and another abroad—with samples to be collected from Mohbad’s remains at the Military Hospital in Yaba in the presence of representatives from both families. The matter has been adjourned till November 11, 2025, for further hearing. In her reaction, Wunmi maintained that she has never been against the DNA process but insisted that it must be done through proper legal channels and not as a result of social media pressure. She explained that she is willing to cooperate once her father-in-law initiates it formally through the court, stressing that no outsider has the right to dictate how it should be done. Her lawyers also pushed back against claims that she was being uncooperative, describing such statements as defamatory and demanding a public apology from those spreading them. Wunmi also clapped back at online commentators who kept dragging her into controversies, making it clear that her priority remains protecting her son and honoring her late husband. While the court’s decision may finally settle questions surrounding Liam’s paternity, many Nigerians have expressed concern that the DNA debate has overshadowed the more pressing issue of justice for Mohbad’s mysterious death. For now, all eyes are on November when the case will resume, with hopes that the truth will bring closure not just to the family, but to fans who continue to demand answers.

Continue Reading

News

Burkina Faso Shuts Down Bill Gates–Backed Mosquito Project 🚫🦟

Published

on

The military government in Burkina Faso has suspended Target Malaria, a project backed by Bill Gates’ foundation that releases genetically modified mosquitoes to fight malaria.

Authorities ordered the NGO to immediately stop all operations, saying foreign projects must align with national priorities. Civil society groups had also raised concerns, urging safer alternatives instead of controversial technology.

Target Malaria, active in Burkina Faso since 2012, said it has complied with all laws and remains open to dialogue. The first GM mosquito release happened back in 2019.

Burkina Faso is one of the world’s malaria hotspots, recording over 8 million cases last year.

This decision follows a wider crackdown: in recent months, the Traoré-led government revoked licenses of 21 foreign NGOs.

Continue Reading

Trending